Avaliação da qualidade do bevacizumabe (Avastin®) fracionado em frascos de vidro de dose única para administração intravítrea

Related authors

• Michelle A. A. Sugimoto
• Vicente de Paulo Coelho Peixoto de Toledo
• Mariem Rodrigues Ribeiro Cunha
• Virginia M. Carregal
• Rodrigo Jorge
• Pedro Leão
• Sílvia Ligorio Fialho
• Armando Silva-Cunha

Related articles

• Prospective evaluation of the effectiveness of combined treatment of macular edema secondary to retinal vein occlusion with intravitreal bevacizumab and dexamethasone implants
• Effects of the epiretinal membrane on the outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion
• Three versus five intravitreal aflibercept injections as the initial loading phase in the treatment of diabetic macular edema: one-year results
• Impact of serous macular detachment on visual recovery in retinal vein occlusion treatment
• Profile of patients treated with intravitreal antiangiogenics in a Brazilian public service with high level of complexity
• ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection
• Quantitative assessment of silicone oil release with siliconized and silicone oil-free syringes by microflow imaging microscopy
• Aflibercept treatment for macular edema with and without serous retinal detachment due to branch retinal vein occlusion
• Baseline predictors of short-term visual outcomes after intravitreal conbercept injection for neovascular age-related macular degeneration
• Staphylococcus hominis: a rare cause of endophthalmitis

Click here to search